Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 1 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 12421316

    Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12416008

    Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  3. US 12409228

    Hydrogel drug delivery systems for the treatment of pediatric growth plate injuries

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  4. US 12409224

    Compositions and methods for the treatment of VEN/AZA resistant acute myeloid leukemia

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  5. US 12396991

    Biomarkers for the diagnosis and treatment of fibrotic lung disease

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  6. US 12396994

    Compositions for improving physiological function with age

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  7. US 12384829

    Pocket engineering of HLA alleles for treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  8. US 12364765

    Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  9. US 12358952

    Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds

    The Regents of the University of Colorado · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  10. US 12350250

    Aggrelytes for treating ocular conditions

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  11. US 12332255

    Methods for monitoring treatment of chronic liver disease

    The Regents of the University of Colorado · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  12. US 12331078

    Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  13. US 12303602

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate · Granted May 20, 2025 · Expires May 15, 2045

    granted
  14. US 12291502

    Topoisomerase II-alpha inhibitors and methods of treating cancer using the same

    The Regents of the University of Colorado, a Body Corporate · Granted May 6, 2025 · Expires May 1, 2045

    granted
  15. US 12285627

    Fabrication and irradiation of a radioactive isotope skin patch

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  16. US 12285357

    Intraocular drug delivery systems and methods of use

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  17. US 12226450

    Peptides and methods for treating disease

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  18. US 12220415

    WEE1 kinase inhibitors and methods of treating cancer using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  19. US 12215060

    Performance of technical ceramics

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  20. US 12202880

    HLA engineering methods and compositions for treatment of autoimmunity

    The Regents of the University of Colorado · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  21. US 12194082

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  22. US 12186384

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  23. US 12161621

    Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease

    The Regents of the University of Colorado · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  24. US 12162912

    Proteins for blocking neurotransmitter release

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted